Learning outcomes
By the end of this lesson you should be able to: define the papulosquamous group and name its four common members; recognise plaque, guttate, flexural, pustular and erythrodermic psoriasis by morphology and distribution, and describe the Koebner and Auspitz signs; recognise the nail, joint and systemic associations of psoriasis and explain the need to screen; describe the histology of psoriasis, lichen planus and pityriasis rosea; treat psoriasis in a stepwise ladder from topical vitamin D analogues to biologics and name the monitoring each requires; and recognise lichen planus, pityriasis rosea, lichen sclerosus and pityriasis rubra pilaris.
Prerequisites
Lesson 2 (morphology), Lesson 4 (exanthems, for the pityriasis rosea differential), and Lesson 8 for the vesicobullous differential of pustular disease.
The big idea
The four questions that separate the members are: is the scale silvery or greasy (psoriasis versus seborrhoeic dermatitis), does it involve the extensor or the flexural surfaces (psoriasis versus eczema), is the papule purple, polygonal and itchy with a white lacy surface (lichen planus), and did it follow a herald patch in a Christmas-tree distribution (pityriasis rosea). Beneath all of them sits one shared biology: an autoimmune T-cell process against an antigen in the epidermis, with the interleukin-23 and Th17 pathway now the centre of psoriasis therapy.
Psoriasis
| Type | Presentation |
|---|---|
| Plaque psoriasis (psoriasis vulgaris) | Well-demarcated, salmon-pink plaques covered with thick silvery-white scale, symmetrically on the elbows, knees, extensor limbs, lumbosacral region and scalp, where the scale extends beyond the hairline. The herald signs: the Koebner phenomenon, and the Auspitz sign — pinpoint bleeding when the scale is lifted |
| Guttate psoriasis | A shower of drop-like, 2 to 10 mm, scaly pink papules over the trunk and limbs, typically 2 to 3 weeks after a streptococcal pharyngitis in a child or young adult; often self-limiting over 6 to 12 weeks, but a third go on to plaque disease |
| Flexural (inverse) psoriasis | Smooth, glazed, well-demarcated, non-scaly erythematous plaques in the axillae, groin, inframammary folds and gluteal cleft; frequently mistaken for candidiasis, but without satellite pustules and with a sharp clean border |
| Pustular psoriasis | Localised: sterile pustules on the palms and soles with a red base (palmoplantar pustulosis). Generalised (von Zumbusch) — see Lesson 11: sheets of febrile sterile pustules with red skin, often after withdrawal of systemic steroids |
| Erythrodermic psoriasis | Erythema and scale over more than 90 per cent of the body surface with systemic upset — see Lesson 11 |
| Nail disease | Pitting, onycholysis with a red-brown oil-drop or salmon patch, subungual hyperkeratosis, thickening and splinter haemorrhages; present in half of patients with skin disease and a marker for joint disease |
NoteThe three landmark signs of psoriasis: Koebner — lesions arising along a scratch or surgical scar, because injury recruits the psoriatic infiltrate; Auspitz — pinpoint bleeding from the thinned suprapapillary epidermis over dilated capillaries after the scale is removed; and Woronoff — a pale halo left around a resolving plaque. All three are physical signs of the same underlying increased epidermal turnover.
| Systemic burden | Detail |
|---|---|
| Psoriatic arthritis | About 30 per cent of patients: distal interphalangeal joint involvement, dactylitis, enthesitis, axial disease and nail dystrophy. Nail pitting and scalp disease predict it. Ask about early morning stiffness and joint pain in every psoriasis patient, and refer for rheumatology assessment |
| Metabolic and cardiovascular | The metabolic syndrome, type 2 diabetes, non-alcoholic fatty liver disease, hypertension and raised cardiovascular mortality are all increased; obesity and smoking worsen the disease |
| Psychological | Anxiety, depression, sexual dysfunction and suicidality are increased out of proportion to visible severity; screen actively |
| Other associations | Uveitis, inflammatory bowel disease, coeliac disease, chronic kidney disease and the recurrence of the disease after lichen sclerosus-like atrophy is uncommon |
Psoriasis treatment ladder
| Step | Therapy | Cautions and monitoring |
|---|---|---|
| Topical for limited disease | Emollients, plus a vitamin D analogue (calcipotriol, calcitriol or tacalcitol), a corticosteroid or a combined preparation, dithranol short-contact, tar, and salicylic acid for thick scale | Calcipotriol stings and must be limited by maximum weekly dose; steroids produce relapse on withdrawal and tachyphylaxis |
| Phototherapy | Narrow-band UVB two or three times a week for 8 to 12 weeks, or PUVA (oral or bath psoralen plus UVA) for resistant disease | Erythema and burning, nausea, and a cumulative skin-cancer risk with PUVA; shield the eyes and genitalia |
| Conventional systemic | Methotrexate (10 to 25 mg weekly with folic acid), ciclosporin (rapid control, blood pressure and renal monitoring), acitretin (teratogenic — contraception must continue for 2 to 3 years after stopping, and it raises lipids and transaminases), fumarates | Liver and renal function, full blood count, blood pressure, lipids, pregnancy prevention |
| Biologic therapy | Tumour necrosis factor inhibitors (adalimumab, etanercept, infliximab), interleukin-12/23 (ustekinumab), interleukin-17 (secukinumab, ixekizumab) and interleukin-23 (guselkumab, risankizumab) | Screen for tuberculosis and hepatitis B before starting; live vaccines are contraindicated; response is measured by PASI 75 or 90 with withdrawal rules for failure |
Watch outGuttate psoriasis needs a throat swab and antistreptolysin titre; treat the streptococcal infection. Do not start systemic immunosuppression for a self-limiting guttate eruption, and do not treat an obstetric patient with erythrodermic psoriasis by ignoring the obstetric trigger — pregnancy both triggers and is affected by every systemic drug on this page.
The other papulosquamous disorders
| Disease | Presentation and histology | Management |
|---|---|---|
| Pityriasis rosea | A herald patch — a single 2 to 5 cm oval scaly plaque on the trunk or proximal limb — followed 1 to 2 weeks later by a generalised eruption of smaller scaly pink macules distributed along the lines of cleavage on the back (a Christmas-tree pattern), usually stopping above the knees. Spares the face, itches mildly and resolves in 6 to 8 weeks. A parakeratotic focus with spongiosis and a perivascular lymphocytic infiltrate on histology. Associated with human herpesviruses 6 and 7 | No treatment is needed for the majority: emollients, topical corticosteroid or UVB for the itch. Exclude secondary syphilis when the rash involves the palms and soles, when the patient has systemic illness or mucosal lesions, or when there is any sexual risk — do a syphilis serology for every atypical pityriasis rosea |
| Lichen planus | The 6 Ps: pruritic, purple, polygonal, planar papules and plaques, with a fine lacy white network (Wickham striae) on the surface. Classically on the flexor surfaces of the wrists, ankles and lower back, arising in scratch lines (a Koebner reaction), with mucous membrane involvement — a lacy white reticulate pattern on the buccal mucosa, erosive painful oral disease and, uncommonly, scarring scalp and genital disease. Histology: compact hyperkeratosis, wedge-shaped hypergranulosis, irregular saw-tooth acanthosis, a band-like lymphohistiocytic infiltrate at the basement membrane zone, and basal vacuolar change with Civatte bodies | Potent topical corticosteroid or intralesional triamcinolone for limited disease, topical tacrolimus or pimecrolimus for the mouth, and systemic retinoids, immunosuppressants or phototherapy for severe or erosive disease. Screen for hepatitis C. Nail and scalp involvement cause scarring alopecia and need dermatological care |
| Lichen planus pigmentosus and lichen amyloidosus | Brown-grey flat papules in the flexures of darker-skinned people (the former) and intensely itchy brown papules on the shins (the latter, with amyloid in the dermis on staining) | Potent topical steroid with occlusion for lichen amyloidosus, phototherapy, and reassurance; both are chronic and misdiagnosed as eczema |
| Lichen sclerosus | White, atrophic, porcelain-like plaques in the anogenital region of women and men, with a sclerosis that fuses the labia and hoods the clitoris (balanitis xerotica obliterans in men), and occasional extragenital plaques | A very potent topical steroid for 3 months then tapering, with regular review for scarring, phimosis and the small risk of squamous cell carcinoma in genital disease |
| Pityriasis rubra pilaris | Orange-red follicular plaques with islands of sparing within a confluent erythema, palmoplantar keratoderma, and a self-limiting juvenile form; the adult form is refractory | Emollients, keratolytics, acitretin or methotrexate; distinguish from erythrodermic psoriasis, which it closely resembles |
| Subacute cutaneous lupus erythematosus | A photosensitive, non-scarring, annular or papulosquamous eruption on the upper trunk and arms, with anti-Ro and anti-La antibodies | Screen for systemic lupus, check renal function and complement, and involve rheumatology |
Common mistakes
Watch outTreating pityriasis rosea without considering secondary syphilis. The two are close mimics: if the rash involves the palms and soles, there is a herald-like patch on the penis, the patient has lymphadenopathy or systemic illness, or there is any sexual exposure, take a syphilis serology before you accept the diagnosis.
Watch outUsing an unopposed topical corticosteroid in flexural psoriasis. The steroid suppresses the plaque temporarily and causes rebound plus atrophy and striae, and flexural psoriasis needs steroid-sparing calcipotriol or calcineurin inhibitors. Flexural disease also needs a differential of candidiasis and tinea, which have satellite lesions.
Watch outMissing the arthritis in the psoriasis patient. Ask about early-morning stiffness, dactylitis, enthesitis and nail pitting in every consultation; delayed referral for psoriatic arthritis produces permanent joint damage, and the patient rarely volunteers the complaint.
Watch outPrescribing acitretin without a pregnancy-prevention plan. Acitretin is teratogenic for 2 to 3 years after the last dose, requires a reliable method of contraception, avoids alcohol which converts it to etretinate, and requires lipid and liver monitoring.
Check your understanding
How do you distinguish plaque psoriasis from discoid eczema, and what bedside manoeuvre helps most?
A patient has a herald patch and a Christmas-tree eruption on the back, but the palms and soles are also involved and there is generalised lymphadenopathy. What must you do before treatment?
Why is a moderate topical corticosteroid not the first choice for a flexural psoriasis in the groin of an obese patient, and what would you give?
Multiple choice
Which feature is most characteristic of plaque psoriasis?
Which question is most important to ask a patient with newly diagnosed psoriasis at every consultation?
A patient with severe psoriasis is started on ciclosporin while a colleague suggests acitretin. Which point applies specifically to acitretin?
Which statement about lichen planus is correct?
Summary and next
The papulosquamous diseases share a scaly papule or plaque and are separated by scale quality, distribution and named signs. Psoriasis is diagnosed from extensor, sharply demarcated plaques with the Koebner and Auspitz signs, has a nail and a joint association, is screened for metabolic and psychological disease, and is treated along a topical, phototherapy, systemic and biologic ladder with monitoring at each step. Pityriasis rosea needs a syphilis serology when the palms, soles or nodes are involved. Lichen planus is purple, polygonal, pruritic, lacy and flexural, with oral, genital and scarring scalp involvement.
Next: the vesicobullous disorders and drug eruptions. In this group the level of the blister decides the prognosis, a biopsy with direct immunofluorescence decides the diagnosis, and a drug history taken with the last eight weeks in mind decides whether your patient survives.